Applicants guidance update history
A list of recent changes to the guidance for applicants.
v20.3 – November 2020
1.3.2 Co- Investigators |
India and China Co-Investigator cost update |
1.6.1 Studentships |
Removal of studentships from Partnership Grants |
2.2.4 Justification of resources |
Removal of studentships from partnership grants |
2.5 Peer review |
Impact of COVID-19 update and Peer Review considerations |
3. Resources
|
Inclusion of the long-term impact of COVID-19 and applications should be based on the information available at the point of submission |
3.3 Overseas costs |
Updates to costs associated with overseas Co-Investigators including Co-Investigators on the OECD DAC list. Developed Countries (inclusive India and China) |
v20.2 – June 2020
2.1 The proposal form |
Information on summary requirements for Official Development Assistance (ODA) transparency and reporting |
2.1 Impact Summary |
Section removed – applicants no longer required to provide an Impact Summary from 01 March 2020 |
2.2.3.4 Impact |
New section – guidance on impact in grant applications for case for support and assessment |
2.2.5 Pathways to Impact |
Section removed – applicants no longer required to provide Pathways to Impact attachment from 01 March 2020 |
v20.1 – February 2020
1.7.2 Applying for a funding opportunity |
Improved guidance to explain users experience when applying for opportunities through Je-S |
2.1 The proposal form |
Guidance updated to include instructions around changes to the ‘pathways to Impact’ and ‘Impact Summary’ for applicants applying after 01 March 2020 |
2.2.3.3 Case for support content |
Further guidance added on adding classifications for public engagement Further detail added around factors on assessment for the track record of applicants registering/publishing previous trials. |
2.2.5 Pathways to impact |
Guidance updated to include instructions around changes to the ‘pathways to Impact’ and ‘Impact Summary’ for applicants applying after 01 March 2020 |
2.2.5.4 Further information |
Section removed as it links to UKRI pathways to Impact guidance which is no longer required after 01 March 2020 |
2.5.2 Applicants' response to reviewers’ comments |
New guidance introduced for applicant’s response page limit for programme grants |
v20.0 – January 2020
Section | Change |
2.2.3.4 Reproducibility and statistical design (recommended annex) |
Further information added regarding the recommended Annex. Link embedded within the section to worked examples of experimental design. |
1.3.3 Researcher Co-Investigator | Link added to RCOI page on MRC website |
1.5.2 Resubmissions and Renewals | Clarity added on outline resubmission policy for the Developmental Pathway Funding Scheme (DPFS) |
2.2.2 Publications | Revised text to clarify UKRI's commitment to recommendations and principles set out by the San Francisco Declaration on Research Assessment (DORA) |
2.2.3.3 Case for support content | Further detail added around factors on assessment for the track record of applicants registering/publishing previous trials. |
2.2.8 Data management plans (DMP) | Changes made to the requirements for intervention studies involving human participants |
2.2.10 Additional requirements for GCRF and Newton Fund calls 2.2.10.1 Gender Equality Statement |
New section added to cover Gender equality requirements for GCRF/Newton fund calls |
2.5.2 Applicants' response to reviewers’ comments | New guidance introduced for applicants response page limit for programme grants |
v19.7 - August 2019
Section | Change |
2.2.3.4 Reproducibility and statistical design (recommended annex) |
Further information added regarding the recommended Annex. Link embedded within the section to worked examples of experimental design. |
v19.6 - August 2019
Section | Change |
3.5.1 NHS costs |
NIHR web links updated. Clarification of which pages of the SoECAT need to be appended to an application. |
1.1 Types of research Organisations (ROs) | Clarification on funding eligibility of MRC Units and Partnership Institutes (Francis Crick Institute, Health Data Research UK, UK Dementia Research Institute) |
3.9 MRC Units and the Francis Crick Partnership Institutes | Clarification on costings for MRC Units and Partnership Institutes (Francis Crick Institute, Health Data Research UK, UK Dementia Research Institute) |
Entire PDF document | Corrections to typos |